Kazuhira Okamoto
Overview
Explore the profile of Kazuhira Okamoto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
386
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yamazaki H, Wada T, Asano H, Fujita H, Okamoto K, Watari H
Diagnostics (Basel)
. 2021 Oct;
11(10).
PMID: 34679592
Most uterine cervical cancers are caused by the persistent infection of the high-risk human papillomavirus (hrHPV). Thus, the hrHPV-DNA test, which examines specimens from the cervix, is the standard screening...
2.
Shimada C, Todo Y, Yamazaki H, Takeshita S, Okamoto K, Minobe S, et al.
Taiwan J Obstet Gynecol
. 2018 Aug;
57(4):541-545.
PMID: 30122575
Objective: The aim of this study was to investigate the feasibility of sentinel lymph node mapping characterized by a cervical tracer injection in endometrial cancer. Materials And Methods: This retrospective...
3.
Park J, Otsuka N, Tomaru U, Suzuki H, Azuma M, Okamoto K, et al.
Hum Pathol
. 2018 Jun;
80:104-112.
PMID: 29936059
PSF3 (Partner of SLD Five 3) is a member of the heterotetrameric complex termed GINS. Previous studies have shown that PSF3 is up-regulated in several cancers and is associated with...
4.
Yamazaki H, Todo Y, Shimada C, Takeshita S, Minobe S, Okamoto K, et al.
J Gynecol Oncol
. 2018 Feb;
29(2):e19.
PMID: 29400012
Objectives: This study evaluated the therapeutic significance of full lymphadenectomy in early-stage ovarian clear cell carcinoma (OCCC). Methods: We retrospectively reviewed records of 127 consecutive patients with pT1/pT2 and M0...
5.
Furuta Y, Todo Y, Yamazaki H, Shimada C, Takeshita S, Okamoto K, et al.
Int J Clin Oncol
. 2017 Sep;
23(1):126-133.
PMID: 28929314
Background: The therapeutic significance of neoadjuvant chemotherapy (NAC) followed by radiation therapy (RT) was negated during the early 1990s. Here, we compared post-NAC RT to surgery for chemo-sensitive cervical squamous...
6.
Todo Y, Takeshita S, Okamoto K, Yamashiro K, Kato H
J Gynecol Oncol
. 2017 Jun;
28(5):e59.
PMID: 28657221
Objective: The aim of this study was to confirm the incidence and implications of a lymphatic spread pattern involving para-aortic lymph node (PAN) metastasis in the absence of pelvic lymph...
7.
Takeshita S, Todo Y, Furuta Y, Okamoto K, Minobe S, Yamashiro K, et al.
Jpn J Clin Oncol
. 2017 Apr;
47(7):604-610.
PMID: 28398498
Objective: Treatment-free interval has been confirmed as a significant prognostic factor in recurrent gynecological cancers. However, treatment-free interval has not been evaluated in previous studies investigating brain metastasis from gynecological...
8.
Endo D, Todo Y, Okamoto K, Suzuki H
Taiwan J Obstet Gynecol
. 2016 Oct;
55(5):751-753.
PMID: 27751432
No abstract available.
9.
Takeshita S, Todo Y, Matsumiya H, Okamoto K, Yamashiro K, Kato H
Jpn J Clin Oncol
. 2016 Sep;
46(11):973-978.
PMID: 27655906
Objective: The aim of the study was to establish a predictive model of survival period after bone metastasis from endometrial cancer. Methods: A total of 28 patients with bone metastasis...
10.
Matsumiya H, Todo Y, Okamoto K, Takeshita S, Yamazaki H, Yamashiro K, et al.
J Gynecol Oncol
. 2016 Aug;
27(6):e55.
PMID: 27550401
Objective: The aim of the study was to establish a predictive model of survival period after bone metastasis from cervical cancer. Methods: A total of 54 patients with bone metastasis...